Ontology highlight
ABSTRACT:
SUBMITTER: Jaramillo S
PROVIDER: S-EPMC5518888 | biostudies-other | 2017 May
REPOSITORIES: biostudies-other
Jaramillo S S Benner A A Krauter J J Martin H H Kindler T T Bentz M M Salih H R HR Held G G Köhne C-H CH Götze K K Lübbert M M Kündgen A A Brossart P P Wattad M M Salwender H H Hertenstein B B Nachbaur D D Wulf G G Horst H-A HA Kirchen H H Fiedler W W Raghavachar A A Russ G G Kremers S S Koller E E Runde V V Heil G G Weber D D Göhring G G Döhner K K Ganser A A Döhner H H Schlenk R F RF
Blood cancer journal 20170526 5
The aim of this cohort study was to compare a condensed schedule of consolidation therapy with high-dose cytarabine on days 1, 2 and 3 (HDAC-123) with the HDAC schedule given on days 1, 3 and 5 (HDAC-135) as well as to evaluate the prophylactic use of pegfilgrastim after chemotherapy in younger patients with acute myeloid leukemia in first complete remission. One hundred and seventy-six patients were treated with HDAC-135 and 392 patients with HDAC-123 with prophylactic pegfilgrastim at days 10 ...[more]